project id: TCGA-PAAD; case submitter id: TCGA-2J-AAB4; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.29; rna integrity number: 7.7; age at index: 48; days to birth: -17794; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1964; age at diagnosis: 17794; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 729.0; icd 10 code: C25.8; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of pancreas; synchronous malignancy: No; tissue or organ of origin: Overlapping lesion of pancreas; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 713; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-2J-AAB4-01A-12; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 30.0; percent stromal cells: 30.0; percent tumor cells: 40.0; percent tumor nuclei: 40.0;